SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001600620-24-000068
Filing Date
2024-05-03
Accepted
2024-05-03 16:16:09
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-05-03

Document Format Files

Seq Description Document Type Size
1 ARS combinedand10xk_ax2024x05x.pdf ARS 18758522
  Complete submission text file 0001600620-24-000068.txt   25831600
Mailing Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6
Business Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6 250-744-2487
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

IRS No.: 981231763 | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-36421 | Film No.: 24913308
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)